David C Knoppert, MScPhm, FCCP, MSc
Children’s Health Research Institute
Scientist, Children’s Optimal Therapeutics Program
Lawson Health Research Institute
Associate Scientist, Children’s Health Research Institute
University of Western Ontario
Assistant Professor, Department of Medicine
Adjunct Professor, Department of Paediatrics
Other Appointments
Liaison Pharmacist, NICU, St. Joseph’s Health Care London
Clinical Coordinator, NICU, St. Joseph's Health Care London
Contact Information
Tel: (519) 685-8500 Ext. 65532
Fax: (519) 646-6003
E-mail: dave.knoppert@sjhc.london.on.ca
Brief Biography
Mr. David Knoppert received his Bachelor of Pharmacy degree from the University of Toronto in 1980. He then completed a Residency in Hospital Pharmacy at University Hospital in London and began as a staff pharmacist at The Hospital for Sick Children in Toronto. In 1986, he completed an MScPhm from the University of Toronto where he worked in Clinical Pharmacology with Drs. Michael Spino and Stuart McLeod. In 1986, he became the NICU Pharmacist at St. Joseph’s Hospital in London. In 2004, he completed his MSc-Clinical Epidemiology from The University of Western Ontario.
Research Interests
Mr. Knoppert’s research interests are in the areas of neonatal therapeutics (pharmacokinetics, pharmacodynamics), the effects of drugs in pregnancy on the newborn and drugs and breastfeeding.
Research Activities
Current research projects include subcutaneous administration of Vitamin A in premature newborns, the prophylactic use of metoclopramide in premature newborns and a dose response study of domperidone use to enhance breast milk production. Future research projects include retrospective studies on the use of enoxaparin and indomethacin in the premature newborn, in addition to the effects of SSRI exposure on the newborn.
Awards and Recognition
Fellow - Awarded by Canadian Society of Hospital Pharmacy
Jack Burghardt Award of Excellence - Awarded by The Salvation Army
Glen S Wither Award for Research - Awarded by Schulich School of Medicine, University of Western Ontario
Funding in support of "Correlation of clinical symptoms with serum levels and CYP2D6 status in newborns who were exposed to paroxetine in utero". - Awarded by Children's Hospital of Western Ontario
Click here to see Publications
